Skip to main content
VCbacked
Log inGet Started

Think Nature

Urasoe, Japan

Think Nature is a researcher startup that specializes in the solutions related to the sustainability of biodiversity and ecosystem services.

$2.4M raised
Apr 2026
Venture - Series Unknown
Life ScienceNatural ResourcesSustainability

Top Investors

Nissay CapitalITOCHU Technology VenturesSumitomo Mitsui Trust InvestmentOkinawa Development Finance CorporationSBI Shinsei Corporate Investment

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Think Nature

How much funding has Think Nature raised?
Think Nature has raised $2.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Who are Think Nature's investors?
Think Nature's investors include Nissay Capital, ITOCHU Technology Ventures, Sumitomo Mitsui Trust Investment, Okinawa Development Finance Corporation, SBI Shinsei Corporate Investment.
Where is Think Nature headquartered?
Think Nature is headquartered in Urasoe, Japan.
What does Think Nature do?
Think Nature is a researcher startup that specializes in the solutions related to the sustainability of biodiversity and ecosystem services.
What stage is Think Nature at?
Think Nature is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Think Nature — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/think-nature. Accessed July 3, 2026.
APA
VCBacked. (2026). Think Nature — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/think-nature
Wikipedia (cite web)
{{cite web |title=Think Nature — Funding & Investors |url=https://www.vcbacked.co/company/think-nature |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Life Science

View all
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Alphina Therapeutics
Westport$40.0M
Neuroglee Therapeutics
Singapore$10.0M
Bluephage
Barcelona$1.5M
Navrogen
Philadelphia